Literature DB >> 1733631

Inhibition of the reactive proliferation of lymphocytes by activated macrophages: the role of nitric oxide.

S Denham1, I J Rowland.   

Abstract

The effects of nitric oxide synthesis by activated macrophages on concanavalin A (Con A) stimulated lymphocyte proliferation and the modulation of these events by extraneous L-arginine concentration were investigated. In 1 mM or 5 mM exogenous L-arginine, inhibition of proliferation of a fixed number of lymphocytes was progressively inhibited in the presence of increasing numbers of macrophages. This inhibition was related to increased nitric oxide synthesis by the macrophages and was suppressed in the presence of NG-monomethyl-L-arginine (NMMA), a specific inhibitor of nitric oxide synthesis. Inhibition of nitric oxide synthesis by 500 microM NMMA was less effective at high concentrations of macrophages, and in 5 mM as compared with 1 mM L-arginine. In the absence of exogenous L-arginine, NMMA inhibited lymphocyte proliferation in the presence of low numbers of macrophages but appeared to promote proliferation at high macrophage concentrations. Membrane separation of lymphocytes and macrophages led to loss of the nitric oxide mediated inhibitory effect on lymphocyte division except at the highest concentrations of macrophages used. Inhibition of lymphocyte proliferation could not be associated with L-arginine depletion of the media by macrophages or by the action of nitrite ions, a product of nitric oxide oxidation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1733631      PMCID: PMC1554247          DOI: 10.1111/j.1365-2249.1992.tb06430.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  14 in total

1.  Differentiation of murine macrophages to express nonspecific cytotoxicity for tumor cells results in L-arginine-dependent inhibition of mitochondrial iron-sulfur enzymes in the macrophage effector cells.

Authors:  J C Drapier; J B Hibbs
Journal:  J Immunol       Date:  1988-04-15       Impact factor: 5.422

2.  Metabolic fate of L-arginine in relation to microbiostatic capability of murine macrophages.

Authors:  D L Granger; J B Hibbs; J R Perfect; D T Durack
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

3.  Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids.

Authors:  L C Green; D A Wagner; J Glogowski; P L Skipper; J S Wishnok; S R Tannenbaum
Journal:  Anal Biochem       Date:  1982-10       Impact factor: 3.365

4.  Activated macrophages kill tumour cells by releasing arginase.

Authors:  G A Currie
Journal:  Nature       Date:  1978-06-29       Impact factor: 49.962

5.  Arginine enhances wound healing and lymphocyte immune responses in humans.

Authors:  A Barbul; S A Lazarou; D T Efron; H L Wasserkrug; G Efron
Journal:  Surgery       Date:  1990-08       Impact factor: 3.982

6.  Macrophage cytotoxicity against schistosomula of Schistosoma mansoni involves arginine-dependent production of reactive nitrogen intermediates.

Authors:  S L James; J Glaven
Journal:  J Immunol       Date:  1989-12-15       Impact factor: 5.422

7.  Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite.

Authors:  J B Hibbs; R R Taintor; Z Vavrin
Journal:  Science       Date:  1987-01-23       Impact factor: 47.728

8.  Arginine, protein malnutrition, and cancer.

Authors:  J V Reynolds; A K Thom; S M Zhang; M M Ziegler; A Naji; J M Daly
Journal:  J Surg Res       Date:  1988-12       Impact factor: 2.192

9.  Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells.

Authors:  D J Stuehr; C F Nathan
Journal:  J Exp Med       Date:  1989-05-01       Impact factor: 14.307

10.  Suppression of in vitro cytotoxic response by macrophages due to induced arginase.

Authors:  J T Kung; S B Brooks; J P Jakway; L L Leonard; D W Talmage
Journal:  J Exp Med       Date:  1977-09-01       Impact factor: 14.307

View more
  13 in total

Review 1.  Cystatin superfamily.

Authors:  Josiah Ochieng; Gautam Chaudhuri
Journal:  J Health Care Poor Underserved       Date:  2010-02

2.  Analysis of the in vitro effect of exogenous nitric oxide on human lymphocytes.

Authors:  A S Shoker; H Yang; M A Murabit; H Jamil; A al-Ghoul; K Okasha
Journal:  Mol Cell Biochem       Date:  1997-06       Impact factor: 3.396

3.  Nitric oxide modulates lipopolysaccharide-induced endothelial platelet endothelial cell adhesion molecule expression via interleukin-10.

Authors:  C B Hebeda; S A Teixeira; E K Tamura; M N Muscará; S B V de Mello; R P Markus; S H P Farsky
Journal:  Clin Exp Immunol       Date:  2011-05-12       Impact factor: 4.330

4.  Nitric oxide production in SJL mice bearing the RcsX lymphoma: a model for in vivo toxicological evaluation of NO.

Authors:  A Gal; S Tamir; S R Tannenbaum; G N Wogan
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

5.  Aggravation of experimental allergic encephalomyelitis (EAE) by administration of nitric oxide (NO) synthase inhibitors.

Authors:  S R Ruuls; S Van Der Linden; K Sontrop; I Huitinga; C D Dijkstra
Journal:  Clin Exp Immunol       Date:  1996-03       Impact factor: 4.330

6.  Mechanisms of tumor-induced immunosuppression: evidence for contact-dependent T cell suppression by monocytes.

Authors:  M L Jaffe; H Arai; G J Nabel
Journal:  Mol Med       Date:  1996-11       Impact factor: 6.354

7.  Tyrosine kinase-dependent and -independent events induced by interleukin-2 stimulation: interleukin-2-mediated NO production required for the induction of lymphokine-activated killer cell activity in rat splenocytes is tyrosine kinase independent.

Authors:  A Juretic; G C Spagnoli; H Hörig; R Shipman; T Kocher; M Samija; M Turic; D Eljuga; F Harder; M Heberer
Journal:  Immunology       Date:  1995-06       Impact factor: 7.397

8.  Protective role of nitric oxide in ocular toxoplasmosis.

Authors:  S Hayashi; C C Chan; R T Gazzinelli; N T Pham; M K Cheung; F G Roberge
Journal:  Br J Ophthalmol       Date:  1996-07       Impact factor: 4.638

Review 9.  Graft-versus-host disease and the Th1/Th2 paradigm.

Authors:  W Krenger; J L Ferrara
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

10.  Myelin-phagocytosing macrophages modulate autoreactive T cell proliferation.

Authors:  Jeroen F J Bogie; Piet Stinissen; Niels Hellings; Jerome J A Hendriks
Journal:  J Neuroinflammation       Date:  2011-07-25       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.